<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s12951-022-01253-8</query><apiKey>87ba7cb21f89ce78154df796840621f4</apiKey><result><total>1</total><start>1</start><pageLength>2</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="publisher-id">12951</journal-id><journal-title-group><journal-title>Journal of Nanobiotechnology</journal-title><abbrev-journal-title abbrev-type="publisher">J Nanobiotechnol</abbrev-journal-title></journal-title-group><issn pub-type="epub">1477-3155</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s12951-022-01253-8</article-id><article-id pub-id-type="manuscript">1253</article-id><article-id pub-id-type="doi">10.1186/s12951-022-01253-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title xml:lang="en">In-situ TiO<sub>2-x</sub> decoration of titanium carbide MXene for photo/sono-responsive antitumor theranostics</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Zhang</surname><given-names>Dong-Yang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Liu</surname><given-names>Hengke</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Younis</surname><given-names>Muhammad Rizwan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Lei</surname><given-names>Shan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Chen</surname><given-names>Yunzhi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au6"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3651-7813</contrib-id><name><surname>Huang</surname><given-names>Peng</given-names></name><address><email>peng.huang@szu.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="corresp" rid="IDs12951022012538_cor6">f</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au7"><name><surname>Lin</surname><given-names>Jing</given-names></name><address><email>jingl@szu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="corresp" rid="IDs12951022012538_cor7">g</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.414906.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1808 0918</institution-id><institution content-type="org-division">Department of Hepatobiliary Surgery</institution><institution content-type="org-name">The First Affiliated Hospital of Wenzhou Medical University Wenzhou</institution></institution-wrap><addr-line content-type="postcode">325000</addr-line><addr-line content-type="city">Zhejiang</addr-line><country country="CN">China</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.508211.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 6004 3854</institution-id><institution content-type="org-division">International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering</institution><institution content-type="org-name">Marshall Laboratory of Biomedical Engineering, Shenzhen University Health Science Center</institution></institution-wrap><addr-line content-type="postcode">518060</addr-line><addr-line content-type="city">Shenzhen</addr-line><country country="CN">China</country></aff></contrib-group><author-notes><fn fn-type="con"><p>Dong-Yang Zhang, Hengke Liu and Muhammad Rizwan Younis contributed equally to this work</p></fn><corresp id="IDs12951022012538_cor6"><label>f</label><email>peng.huang@szu.edu.cn</email></corresp><corresp id="IDs12951022012538_cor7"><label>g</label><email>jingl@szu.edu.cn</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>1</month><year>2022</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2022</year></pub-date><volume>20</volume><issue seq="53">1</issue><elocation-id>53</elocation-id><history><date date-type="registration"><day>10</day><month>1</month><year>2022</year></date><date date-type="received"><day>30</day><month>10</month><year>2021</year></date><date date-type="accepted"><day>9</day><month>1</month><year>2022</year></date><date date-type="online"><day>28</day><month>1</month><year>2022</year></date></history><permissions><copyright-statement content-type="compact">© The Author(s) 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="uri">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract xml:lang="en" id="Abs1"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1">Sonodynamic therapy (SDT) has emerged as a noninvasive therapeutic modality that involves sonosensitizers and low-intensity ultrasound. However, owing to the rapid recombination of charge carriers, most of the sonosensitizers triggered poor reactive oxygen species (ROS) generation, resulting in unsatisfactory sonodynamic therapeutic effects.</p></sec><sec id="ASec2"><title>Results</title><p id="Par2">Herein, a photo/sono-responsive nanoplatform was developed through the <italic>in-situ</italic> systhesis of TiO<sub>2-x</sub> on the surface of two-dimensional MXene (titanium carbide, Ti<sub>3</sub>C<sub>2</sub>) for photoacoustic/photothermal bimodal imaging-guided near-infrared II (NIR-II) photothermal enhanced SDT of tumor. Because of several oxygen vacancies and smaller size (~ 10 nm), the <italic>in-situ</italic> formed TiO<sub>2-x</sub> nanoparticles possessed narrow band gap (2.65 eV) and high surface area, and thus served as a charge trap to restrict charge recombination under ultrasound (US) activation, resulting in enhanced sonodynamic ROS generation. Moreover, Ti<sub>3</sub>C<sub>2</sub> nanosheets induced extensive localized hyperthermia relieves tumor hypoxia by accelerating intratumoral blood flow and tumor oxygenation, and thus further strengthened the efficacy of SDT. Upon US/NIR-II laser dual-stimuli, Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> nanoplatform triggered substantial cellular killing in vitro and complete tumor eradication in vivo, without any tumor recurrence and systemic toxicity.</p></sec><sec id="ASec3"><title>Conclusion</title><p id="Par3">Our work presents the promising design of photo/sono-responsive nanoplatform for cancer nanotheranostics.</p></sec><sec id="ASec4"><title>Graphical Abstract</title><p><fig id="Figa" position="anchor"><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1253_Figa_HTML.png" position="anchor" id="MO20"/></fig></p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Titanium carbide</kwd><kwd>Oxygen deficient titanium dioxide</kwd><kwd>Photoacoustic imaging</kwd><kwd>Photothermal therapy</kwd><kwd>Sonodynamic therapy</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Basic Research Program of Shenzhen</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">JCYJ20200109105620482</award-id><principal-award-recipient><name><surname>Lin</surname><given-names>Jing</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>Basic Research Program of Shenzhen</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">JCYJ20180507182413022</award-id><principal-award-recipient><name><surname>Huang</surname><given-names>Peng</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>53</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2022</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2022</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>Yes</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2022</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>10</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/12951_2022_Article_1253.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Chemistry</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Biotechnology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Nanotechnology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Molecular Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Chemistry and Materials Science</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="ESMHint"><title>Supplementary Information</title><p>The online version contains supplementary material available at <ext-link xlink:href="10.1186/s12951-022-01253-8" ext-link-type="doi">https://doi.org/10.1186/s12951-022-01253-8</ext-link>.</p></notes></front><body><sec id="Sec1"><title>Introduction</title><p id="Par57">Sonodynamic therapy (SDT), a type of non-invasive tumor modality, offered promising advantages than conventional tumor treatment, such as high tissue penetration, high spatiotemporal selectivity, and non-invasiveness [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR6">6</xref>]. In SDT, sonosensitizers triggered reactive oxygen species (ROS) production under ultrasound (US) stimulation, leading to selective tumor cell killing with minimal damage to nearby healthy cells [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. Hence, several organic and inorganic sonosensitizers have been developed, however, organic sonosensitizers are mainly suffer from high skin phototoxicity [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Alternatively, inorganic sonosensitizers with negligible phototoxicity and enhanced chemical stability, respectively, have shown great promise for tumor SDT. Especially, titanium dioxide (TiO<sub>2</sub>) as an inorganic sonosensitizer, has been widely employed, but the rapid recombination (50 ± 30 ns) of US-mediated charge carriers (electron–hole pair) endows TiO<sub>2</sub> with poor ROS quantum yield, resulting in limited SDT efficacy [<xref ref-type="bibr" rid="CR14">14</xref>]. Previous reports suggested that the presence of oxygen deficiencies within TiO<sub>2</sub> or the integration of TiO<sub>2</sub> with noble metals could improve the SDT activity [<xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR18">18</xref>], however, because of the large size TiO<sub>2</sub> NPs, the adsorption of oxygen molecules onto the surface of TiO<sub>2</sub> is remarkably poor, leading to unsatisfactory ROS yield. Thus, an optimal design engineering of inorganic sonosensitizers is desirable to overcome these limitations, promoting high SDT performance under US activation. Moreover, as the SDT reaction is exclusively dependent on tissues oxygen, the continuous sonodynamic ROS generation induced severe tumor hypoxia due to oxygen depletion, and hence, restricts the overall SDT efficacy. Therefore, the integration of SDT with other non-invasive tumor treatment modalities, which may complement SDT effects, is greatly needed.</p><p id="Par58">Being activated by an external light source, photothermal therapy (PTT) is an ideal non-invasive treatment modality, which induced irreversible destruction of tumor cells via localized hyperthermia generated by photothermal agents [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR22">22</xref>]. As photothermal agents with NIR-I light absorption have been actively developed, NIR-I tumor PTT is well-established, while PTT of deep-seated tumors at second biowindow (NIR-II) is yet limited. Moreover, though NIR-I laser light excitation endows PTT with sufficient penetration depth, an inhomogeneous thermal distribution as well as tumor self-regulation limit the complete photothermal eradication of deep-seated tumors, favoring tumor recurrence and metastasis [<xref ref-type="bibr" rid="CR23">23</xref>]. Previously, Xia et al. demonstrated photothermal enhanced photodynamic therapy (PDT) of Hela tumor in vivo under low power single NIR-I laser activation [<xref ref-type="bibr" rid="CR24">24</xref>]. They suggested that localized hyperthermia could not only activate PDT by the controlled release of indocyanine green, but also relieve PDT-induced tumor hypoxia, leading to accelerate photodynamic tumor killing. Recently, our group have shown that PTT under both NIR-I and NIR-II laser excitation, could enhance multimodal tumor therapies such as starvation therapy, chemodynamic therapy, and immunotherapy [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR28">28</xref>]. Notably, it has been reported that PTT could complement SDT as mild hyperthermia accelerates intratumoral blood flow and tumor oxygenation, which promote sonodynamic ROS generation by relieving tumor hypoxia [<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR31">31</xref>]. Whereas, under US activation, SDT also complements PTT by ROS-mediated tumor cell killing as well as replenishment of thermally resistant deeply localized tumors due to the high penetration depth of US [<xref ref-type="bibr" rid="CR32">32</xref>]. Considering the prominent features of individual PTT and SDT, their integration would be highly advantageous to overcome their inherent limitations and achieve ultimate therapeutic effects.</p><p id="Par59">Two-dimensional MXene nanomaterials, such as titanium carbide (Ti<sub>3</sub>C<sub>2</sub>), are widely used in biomedical applications [<xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR40">40</xref>]. Particularly, Ti<sub>3</sub>C<sub>2</sub> with good absorption in NIR-II region, excellent photothermal performance, and low toxicity, has become a potential photothermal therapeutic agent. Furthermore, multimodal imaging capacity of Ti<sub>3</sub>C<sub>2</sub> provides an opportunity to monitor nanomaterials biodistribution as well as effectively guide the tumor treatment in vivo. Owing to the promising biomedical characteristics, Ti<sub>3</sub>C<sub>2</sub> is an ideal candidate to couple with sonosensitizer to trigger PTT enhanced SDT of deep-seated tumors at second biowindow. In this study, a Ti<sub>3</sub>C<sub>2</sub>-based 2D nanotheranostic hybrid is constructed <italic>in-situ</italic> for duplex photoacoustic (PA)/photothermal imaging-guided synergistic PTT/enhanced SDT at NIR-II biowindow (Scheme <xref rid="Sch1" ref-type="fig">1</xref>). In brief, the multifunctional nanohybrid (Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>) is developed by a hydrothermal method via<italic> in-situ</italic> growth of TiO<sub>2-x</sub> nanoparticles with several oxygen defects onto Ti<sub>3</sub>C<sub>2</sub> nanosheets. The resultant Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> were further modified with polyethylene glycol (PEG), defined as TTP, showing good biocompatibility and aqueous dispersibility in various physiological solutions. The as-obtained TTP not only exhibits good photothermal performance, but also demonstrates superior ROS production under US excitation than TiO<sub>2</sub> due to high surface area and the presence of multiple oxygen vacancies, promoting enhanced separation of charge carriers (electron–hole pairs). A remarkably higher therapeutic efficacy was achieved under dual-modal PA/PT imaging guidance both in vitro and in vivo, without any obvious toxic effects after intravenous administration. This study provides a promising strategy of photo-sonoinduced theranostics of deeply localized tumors.<fig id="Sch1"><label>Scheme 1</label><caption xml:lang="en"><p>Schematic illustration of <bold>A</bold> the preparation of <italic>in-situ</italic> fabricated TTP nanohybrids and <bold>B</bold> their application in bimodal PA/PT imaging guided synergistic photothermal-enhanced sonodynamic therapy in NIR-II biowindow</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1253_Sch1_HTML.png" id="MO1"/></fig></p></sec><sec id="Sec2" sec-type="materials|methods"><title>Material and methods</title><sec id="Sec3"><title>Preparation of Ti3C2@TiO2-x-PEG (TTP)</title><p id="Par60">Ti<sub>3</sub>C<sub>2</sub> nanosheets were obtained following the reported literature [<xref ref-type="bibr" rid="CR36">36</xref>]. Then, 2D Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub> hybrid was fabricated according to the previous report with slight modification. 100 mg of Ti<sub>3</sub>C<sub>2</sub> was dispersed in 3.0 M hydrochloric acid (15 mL) containing 0.04 M ammonium fluoride. Above dispersion was transferred to the Teflon stainless steel autoclave and kept at 200 °C for 12 h. After centrifugation and washing with deionized (DI) water, the as-collected Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub> precipitate was added to hydrazine hydrate solution (25 mL, 50 wt%) under stirring. Next, the suspension was further transferred to the Teflon stainless steel autoclave and kept at 200 °C for 12 h. The final Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> hybrid was obtained by centrifugation and washing with DI water.</p><p id="Par61">To improve the solubility and biocompatibility of Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>, 20 mg of DSPE-PEG dissolved in chloroform (20 mL) was added dropwise into Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> ethanol solution (2 mg/mL, 20 mL) under ultrasonication. The product was obtained by evaporating the solvent and then resuspended in phosphate buffered saline (PBS), and finally stored at 4 °C for future use.</p></sec><sec id="Sec4"><title>In vivo toxicity</title><p id="Par62">BALB/c female mice (n ≥ 3) were intravenously (<italic>i.v.</italic>) injected with TTP nanohybrids (4 mg/mL, 200 μL) or PBS (200 μL). The body weight of mice was recorded every 3 days. The blood and primary organs (kidneys, lungs, spleen, liver, heart) were acquired after 30 days post-injection. The blood was used to perform hematologic analysis and the primary organs were stained by hematoxylin and eosin (H&amp;E). All animal experiments were conducted as per the approved institutional guidelines for the care of laboratory animals of Shenzhen University.</p></sec><sec id="Sec5"><title>Photoacoustic/thermal imaging and biodistribution of nanohybrids in vivo</title><p id="Par63">PA signals of the varying concentrations of TTP nanohybrid in solution were recorded by a photoacoustic imager. For in vivo NIR-II PA imaging, 4T1 tumor-bearing mice (n = 3) were <italic>i.v.</italic> injected with TTP nanohybrids (2 mg/mL, 200 μL), and the PA signals were monitored at different time points (0, 1, 2, 4, 8, and 24 h).</p><p id="Par64">4T1 tumor-bearing BALB/c nude mice were <italic>i.v.</italic> injected with TTP nanohybrid (2 mg/mL, 200 μL). After 4 h post-injection, the tumors were irradiated by a 1064 nm laser and the real-time temperature changes were monitored with a thermal imager.</p><p id="Par65">4T1 tumor-bearing nude mice (n = 3) were <italic>i.v.</italic> injected with TTP nanohybrid (2 mg/mL, 200 μL). After 24 h post-injection, the mice were euthanized to collect the primary organs. The primary organs were digested by aqua regia and determined by ICP-MS. The biodistribution of Ti (% ID of Ti per gram of tissues) was calculated in primary organs.</p></sec><sec id="Sec6"><title>In vivo treatment</title><p id="Par66">4T1 tumor-bearing BALB/c nude mice with ~ 50 mm<sup>3</sup> tumor volume, were randomly divided into 6 groups (n ≥ 5) as follows: (i) PBS, (ii) laser + US (iii) TTP nanohybrid, (iv) TTP nanohybrid + US, (v) TTP nanohybrid + laser, (vi) TTP nanohybrid + laser + US. After 4 h post-injection, the tumors were treated with laser irradiation (1064 nm, 0.8 W/cm<sup>2</sup>, 10 min) or/and US (1 W/cm<sup>2</sup>, 5 min). The tumor volumes and body weights of mice were recorded every 2 days. The tumor volume was calculated based on the formula: V (mm<sup>3</sup>) = AB<sup>2</sup>/2, where A and B are the maximum length (mm) and the minimum width (mm) of the tumor, respectively. The body weights of mice were recorded every 2 days. The mice were sacrificed at 14th day post-treatment to collect tumors, serum, and primary organs. The tumors were photographed, weighed, and stained by Terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) assay. The serum was used to determine the levels of liver and kidney function indicators, while the primary organs and tumor were stained by H&amp;E for histopathological investigations.</p></sec></sec><sec id="Sec7"><title>Results and discussion</title><sec id="Sec8"><title>Synthesis and characterization</title><p id="Par67">The development of TTP nanohybrid was carried out in several steps. In brief, bulk Ti<sub>3</sub>C<sub>2</sub> powder was first exfoliated via ultrasonication by using TPAOH as an intercalating agent, resulting in the formation of 2D Ti<sub>3</sub>C<sub>2</sub> nanosheets with an approximate lateral dimension of 150 nm (Fig. <xref rid="Fig1" ref-type="fig">1</xref>A). Next, TiO<sub>2</sub> NPs were grown in situ onto the as-obtained 2D Ti<sub>3</sub>C<sub>2</sub> nanosheets by hydrothermal method [<xref ref-type="bibr" rid="CR41">41</xref>]. Compared to the usually prepared TiO<sub>2</sub> NPs (~ 100 nm) [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], in situ fabricated TiO<sub>2</sub> NPs were much smaller (~ 10 nm) in diameter as revealed by TEM (Fig. <xref rid="Fig1" ref-type="fig">1</xref>B). Considering an inverse relationship between the NPs size and their surface area, the as-obtained TiO<sub>2</sub> NPs with high surface area could facilitate higher surface adsorption of oxygen molecules and the separation of electron–hole pairs, promoting higher ROS generation [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. Finally, an engineering of <italic>in-situ</italic> developed Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub> was performed through hydrazine hydrate reduction method [<xref ref-type="bibr" rid="CR46">46</xref>], which induced multiple oxygen defects within TiO<sub>2</sub> NPs, resulting in the formation of Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> nanohybrid. Notably, no apparent aggregation or morphological change was seen after modifications as shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>C, D. The selected area electron diffraction (SAED) pattern of Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>E, inset) indicated the crystalline nature of TiO<sub>2</sub>, whereas the lattice spacings of 0.352 nm were assigned to (101) plane of anatase TiO<sub>2</sub> [<xref ref-type="bibr" rid="CR47">47</xref>]. Meanwhile, energy dispersive X-ray spectroscopy (EDS) indicated the presence of titanium, oxygen, and carbon elements in Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>F, G and Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S1A, B). Compared to Ti<sub>3</sub>C<sub>2</sub> (20 nm), ~ 40–80 nm of height increases were noticed for Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub> and Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>, indicating in situ production and the decoration of TiO<sub>2</sub> onto Ti<sub>3</sub>C<sub>2</sub> (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S2). The X-ray diffraction (XRD) spectrum of TiO<sub>2-x</sub>@Ti<sub>3</sub>C<sub>2</sub> was well-indexed with TiO<sub>2</sub> (JCPDS no. 21–1272) and Ti<sub>3</sub>C<sub>2</sub> (JCPDS no. 32–1383) as shown in Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S3. The elemental composition and oxygen vacancies were further confirmed by XPS spectroscopy. Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S4A–E and Fig. <xref rid="Fig1" ref-type="fig">1</xref>H, I verified the presence of titanium (25.92%, 15.7%), oxygen (52.47%, 25.17%) and carbon (21.62%, 44.74%) in Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> hybrid, respectively, while O 1 s peak is negatively shifted from 529.9 (Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>) to 529.2 eV in Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> nanohybrid (Fig. <xref rid="Fig1" ref-type="fig">1</xref>H, I), which is attributed to the existence of oxygen vacancies within Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>, favoring highly efficient ROS production [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. The quantitative analysis also indicated a prominent decrease in O/Ti ratio from 2 to 1.6 after reduction (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S4F), implying the creation of oxygen vacancies in Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>. Such a thorough characterizations proved the successful fabrication of <italic>in-situ</italic> 2D Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> nanohybrid with desired oxygen deficiencies to accelerate ROS generation.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>TEM images of <bold>A</bold> Ti<sub>3</sub>C<sub>2</sub>, <bold>B</bold> Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>, and <bold>C</bold> Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>. The scale bars in <bold>A</bold>, <bold>B</bold> and <bold>C</bold> are 200 nm, 200 nm and 100 nm, respectively. <bold>D</bold> and <bold>E</bold> HR-TEM images of the Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>. The inset in Fig. D is the SAED pattern of TiO<sub>2-x</sub></p><p>taken from the yellow rectangular box in Fig. E. The scale bars in <bold>D</bold> and <bold>E</bold> are 20 and 5 nm, respectively. <bold>F</bold> TEM elemental mapping images of Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> hybrid (Ti: blue; O: green; C: red; merged image). Scale bar: 50 nm. <bold>G</bold> Quantitative EDS elemental analysis of Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub> and Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>. <bold>H</bold> O 1 s XPS spectrum of <bold>I</bold> Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub> and <bold>G</bold> Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>. <bold>J</bold> Absorption spectra of Ti<sub>3</sub>C<sub>2</sub>, Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>, Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>, and TTP</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1253_Fig1_HTML.png" id="MO2"/></fig></p><p id="Par68">Later, Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> was surface functionalized with DSPE-PEG, which imparts an aqueous solubility and biocompatibility. Notably, the surface PEGylation did not induce any observable morphological change in the resultant TTP and Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>-PEG as shown in Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S5A, B. FT-IR spectra of TTP showed the presence of –CH<sub>2</sub> and C–O bonds at 2870 and 1100 cm<sup>−1</sup>, respectively, which are assigned to the DSPE-PEG modification (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S6), while the amount of PEG loaded onto Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> hybrid was about 3% as quantitatively determined by TGA (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S7), indicating the successful surface grafting of Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> hybrid by PEG. The hydrodynamic diameter of TTP was about 170 nm as determined by DLS (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S8), whereas, the surface zeta potential of Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>-PEG and TTP was about −7.8 and −11.2 eV, respectively, suggesting limited protein binding and longer blood circulation (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S9) [<xref ref-type="bibr" rid="CR50">50</xref>]. Owing to PEG grafting, TTP and Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>-PEG exhibited good stability in different physiological solutions such as PBS, Dulbecco’s modified eagle medium (DMEM), and fetal bovine serum (FBS) as shown in Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S10A, B. Meanwhile, no notable change was recorded in the hydrodynamic diameter of TTP and Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>-PEG under different physiological solutions for 3 days, verifying the excellent colloidal stability of TTP (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S10C, D). UV–vis/NIR absorption spectroscopy indicated the broadband absorption of TTP in NIR-II region without any particular absorption peak (Fig. <xref rid="Fig1" ref-type="fig">1</xref>J), which is solely ascribed to the presence of 2D Ti<sub>3</sub>C<sub>2</sub> sheets, suggesting the potential of as-designed TTP hybrid for dual-modal PT/PA imaging and PTT at second biowindow.</p></sec><sec id="Sec9"><title>Evaluation of photothermal and sonodynamic capacity</title><p id="Par69">Considering the good NIR-II absorption, the photothermal capacity of TTP was investigated. Figure <xref rid="Fig2" ref-type="fig">2</xref>A, B displayed significant temperature enhancement in TTP solution under 1064 nm laser irradiation (0.8 W/cm<sup>2</sup>) for 5 min, which is directly proportional to the irradiation time and TTP concentration, respectively. Furthermore, the calculated photothermal conversion efficiency (PCE, <italic>η</italic>) of TTP was about 35.8% (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S11A, B) [<xref ref-type="bibr" rid="CR51">51</xref>], which is superior or even comparable to many previously reported photothermal nanoagents [<xref ref-type="bibr" rid="CR52">52</xref>–<xref ref-type="bibr" rid="CR55">55</xref>]. Notably, under 5 repetitive laser on/off cycles, no apparent temperature decrease was recorded as shown in Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S12A. Moreover, the absorption spectrum and TEM morphological characterization did not show any particular change in TTP even after 1064 nm laser irradiation for 20 min, suggesting the excellent photothermal stability of TTP (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S12B, C). Inorganic TiO<sub>2</sub> nanoparticles have been widely reported as sonosensitizers, capable of ROS production such as singlet oxygen (<sup>1</sup>O<sub>2</sub>) and hydroxyl radicals (·OH), etc. under US irradiation [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. Therefore, electron spin resonance (ESR) spectroscopy was employed to determine the ROS generation by TTP under US activation. Figure <xref rid="Fig2" ref-type="fig">2</xref>C presented the characteristic (1:1:1) peaks of <sup>1</sup>O<sub>2</sub> after US stimulation of both Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>-PEG and TTP group, respectively. The <sup>1</sup>O<sub>2</sub> generation ability of TTP was further evaluated by using 1, 3-diphenylisobenzofuran (DPBF) probe. Figure <xref rid="Fig2" ref-type="fig">2</xref>D and Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S13 showed time-dependent gradual decrease in DPBF absorbance at 410 nm by both Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>-PEG and TTP group, while the control group did not reduce the DPBF absorption at all. It is worth mentioning that TTP showed stronger <sup>1</sup>O<sub>2</sub> production capacity than Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>-PEG, which is possibly ascribed to the presence of several oxygen vacancies within TiO<sub>2-x.</sub> Notably, these oxygen vacancies played a vital role as they promoted effective separation of charge carriers (electron–hole pairs), and thus facilitate an enhanced interaction between charge carriers and surface adsorbed oxygen molecules, leading to enhanced ROS generation. Meanwhile, the concentration and US power-dependent <sup>1</sup>O<sub>2</sub> production was also recorded by TTP as shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>E, F and Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S14A, B. Besides <sup>1</sup>O<sub>2</sub>, the characteristic (1:2:2:1) peaks of 5,5-Dimethyl-1-pyrroline N-oxide (DMPO) and ·OH adducts were appeared both in TiO<sub>2</sub>@Ti<sub>3</sub>C<sub>2</sub>-PEG and TTP groups, indicating the generation of ·OH ions (Fig. <xref rid="Fig2" ref-type="fig">2</xref>G). Similarly, a ·OH indicator TPA, which emits fluorescence after reacting with ·OH under UV light, was also used to detect the ability of TTP to produce ·OH under US stimulation. As shown in Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S15, a strong fluorescence signal is generated at 422 nm after Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>-PEG and TTP activation by US. However, the control group and US irradiation alone showed much weaker fluorescence signal. The quantitative analysis suggested that TTP has a stronger ·OH production ability than Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>-PEG. Similar to <sup>1</sup>O<sub>2</sub>, the production of ·OH is also dependent on TTP concentration and US power density (Fig. <xref rid="Fig2" ref-type="fig">2</xref>H, I). These results verified that TTP holds excellent <sup>1</sup>O<sub>2</sub> and ·OH production capacity under ultrasonic stimulation. For better apprehension of the sonodynamic performance of Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>, the band gap calculation was made by Kubelka–Munk function, which was about 3.32 and 2.65 eV for TiO<sub>2</sub> and Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>, respectively (Fig. <xref rid="Fig2" ref-type="fig">2</xref>J). Such a narrow band gap of Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub> than TiO<sub>2</sub> NPs could be ascribed to the overlapping oxygen deficiency induced defect states with the band edge of the semiconductor. Thereby, Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x2</sub> served as a charge trap, and remarkably restricts the charge recombination (electron–hole pairs) under US excitation, promoting an enhanced sonodynamic ROS generation during SDT (Fig. <xref rid="Fig2" ref-type="fig">2</xref>K).<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p><bold>A</bold> The real-time thermal images and <bold>B</bold> the corresponding heating curves of the varying concentrations of TTP aqueous solutions. <bold>C</bold> ESR spectra of <sup>1</sup>O<sub>2</sub>/TEMP adduct by incubating Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>-PEG or TTP with TEMP (20 mM). <bold>D</bold> The absorbance profile of DPBF at 425 nm under different conditions and US stimulation (1 W/cm<sup>2</sup>, 1 MHz) for 5 min. <bold>E</bold> The absorbance spectra of DPBF treated with different concentrations (0–200 μg/mL) of TTP under US irradiation (1 W/cm<sup>2</sup>, 1 MHz, 5 min). <bold>F</bold> The absorbance spectra of DPBF treated with 50 μg/mL of TTP under US irradiations with different power density (0–1.6 W/cm<sup>2</sup>, 1 MHz, 5 min). <bold>G</bold> ESR spectra of ·OH/DMPO adduct by incubating Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2</sub>-PEG or TTP with DMPO (10 mM). <bold>H</bold> The fluorescence intensity of NaOH solution (2 mM) containing TPA (0.5 mM) and treated with different concentrations of TTP, followed by US irradiation (1 W/cm<sup>2</sup>, 1 MHz, 3 min). <bold>I</bold> The fluorescence intensity of NaOH solution containing TPA (0.5 mM) and TTP (50 μg/mL) irradiated with US of different power density (0–1.6 W/cm<sup>2</sup>, 1 MHz, 3 min). <bold>J</bold> Optical band gaps of TTP and TiO<sub>2</sub>. <bold>K</bold> Schematic illustration of the US-induced ROS generation by TTP hybrid, and the proposed mechanism of accelerated sonodynamic performance of TTP by enhanced separation of charge carriers through oxygen defects</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1253_Fig2_HTML.png" id="MO3"/></fig></p></sec><sec id="Sec10"><title>In vitro combined PTT/SDT</title><p id="Par70">The in vitro cellular uptake of TTP was determined by ICP-MS. The cellular uptake mechanism of TTP was investigated by using various inhibitors. As presented in Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S16, the cellular uptake of TTP was significantly reduced when incubated with chlorpromazine or at 4 ℃, suggesting that TTP entered into cells through an energy-dependent and clathrin-mediated endocytosis pathway. As shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>A, the Ti content in 4T1 cells increases gradually with an increase in incubation time, indicating an efficient cellular internalization of TTP. While, MTT assay revealed no potential cytotoxicity of internalized TTP on 4T1 and human embryonic kidney (HEK293T) cells in dark, suggesting good biocompatibility (Fig. <xref rid="Fig3" ref-type="fig">3</xref>B and Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S17). However, TTP substantially reduced the cellular viability of 4T1 cells under either 1064 nm laser (PTT) or US (SDT) activation, respectively. The cellular viability was reduced up to 45% and 39% by individual PTT and SDT treatment alone (Fig. <xref rid="Fig3" ref-type="fig">3</xref>C), whereas, the combined PTT/SDT triggered significant cellular killing, resulting in a dramatic decrease (16.5%) in cells viability, suggesting superior therapeutic killing performance of combined PTT/SDT treatment than either PTT or SDT alone. MTT findings were also further endorsed by live and dead assay (Fig. <xref rid="Fig3" ref-type="fig">3</xref>D) and Annexin V-FITC and PI staining (Fig. <xref rid="Fig3" ref-type="fig">3</xref>E) as much higher proportion of dead cells (apoptosis and necrosis) were observed after dual laser/US treatment (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S18), verifying an extensive in vitro cellular killing by synergistic PTT/SDT.<fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p><bold>A</bold> Estimation of Ti content in 4T1 cells after treated with TTP at indicated time points as determined by ICP-MS. <bold>B</bold> Relative viabilities of 4T1 cells treated with various concentrations of TTP nanohybrids for 24 h in dark. <bold>C</bold> Cellular viability of 4T1 cells incubated with TTP (100 μg/mL) under different conditions like: (I) Control, (II) Laser, (III) US, (IV) TTP, (V) TTP + US, (VI) TTP + Laser, and (VII) TTP + Laser + US. Statistical significance compared with the control group is shown (**<italic>p</italic> &lt; 0.01 and ***<italic>p</italic> &lt; 0.001). <bold>D</bold> Confocal laser scanning microscopic (CLSM) images of 4T1 cells stained by Calcein-AM and PI after different treatments as mentioned. The scale bar is 50 μm. <bold>E</bold> Flow cytometric analysis of 4T1 cells after different indicated treatments. <bold>F</bold> CLSM images of in vitro ROS generation in 4T1 cells as stained by DCF (green) after different treatments, while the cell nucleus was stained by Hoechst 33,342 dye (blue). The scale bar is 10 μm</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1253_Fig3_HTML.png" id="MO4"/></fig></p><p id="Par71">Considering that <sup>1</sup>O<sub>2</sub> and ·OH can be produced under ultrasonic stimulation in an aqueous solution. The ROS probe 2,7-dichlorofluorescein diacetate (DCFH-DA) was utilized to assess ROS production in vitro in 4T1 cells. Negligible green fluorescence was noticed in cells after treated with US, laser, or TTP alone, while an obvious green fluorescence was seen after simultaneous treatment with TTP and US (Fig. <xref rid="Fig3" ref-type="fig">3</xref>F), implying significant ROS production.</p></sec><sec id="Sec11"><title>In vivo biocompatibility</title><p id="Par72">Biosafety is an important prerequisite for the development of nanodrugs in biomedical field. Hence, the in vivo biocompatibility of TTP was evaluated by hemolysis assay, hematology analysis, and H&amp;E staining of the major organs (heart, liver, spleen, lungs, and kidneys). Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S19 showed no adverse effects of TTP on red blood cells, while all the hematological parameters, including liver (aspartate transaminase, AST, alanine aminotransferase, ALT), kidney function (blood urea nitrogen, BUN, creatinine, CRE), and other blood biochemical indicators as shown in Fig. <xref rid="Fig4" ref-type="fig">4</xref>A–F, were also in normal range like PBS-treated control mice. In addition, H&amp;E analysis did not display any apparent inflammation in major organs (Fig. <xref rid="Fig4" ref-type="fig">4</xref>G). Moreover, like PBS-treated mice, no particular change was recorded in the body weight of TTP-treated mice even after one month (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S20). Collectively, these results verified the good biocompatibility and biosafety of TTP in vivo.<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p><bold>A</bold> Different levels of kidney and liver function indicators <bold>B</bold> in serum as mentioned after different treatments. Blood panel analysis: <bold>C</bold> hemoglobin (HGB), mean corpuscular hemoglobin concentration (MCHC), and platelets (PLT); <bold>D</bold> red blood cells (RBC), mean platelet volume (MPV), mean corpuscular hemoglobin (MCH); <bold>E</bold> white blood cells (WBC), lymphocyte (LYM), monocyte (MON); <bold>F</bold> hematocrit (HCT), mean corpuscular volume (MCV), and platelet distribution width (PDW) of mice treated with PBS or TTP (4 mg/mL, 200 μL). <bold>G</bold> H&amp;E staining of major organs after different treatments. The scale bar is 100 μm</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1253_Fig4_HTML.png" id="MO5"/></fig></p></sec><sec id="Sec12"><title>In vivo biodistribution and duplex PA/PT imaging</title><p id="Par73">Prior to the determination of in vivo therapeutic potential of TPP, we assessed the in vivo biodistribution of TTP by PA imaging and ICP-MS, respectively. As expected, the PA signal intensity was positively correlated with the concentration of TTP (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S21). As can be seen in Fig. <xref rid="Fig5" ref-type="fig">5</xref>A, B, compared to pre-injection, the PA signal intensity is significantly enhanced in tumor tissues after post-injection, indicating an effective tumor accumulation of TTP. Importantly, the highest PA signal was found at 4 h post-injection, which provides an effective guidance and optimal treatment time for tumor PTT in vivo. Next, the Ti content in major organs of mice was detected by ICP-MS. Figure <xref rid="Fig5" ref-type="fig">5</xref>C displayed prominent accumulation of TTP in reticuloendothelial system <italic>e.g.</italic>, liver and spleen, whereas, 5% ID/g of TTP was found in tumor tissues, which is advantageous for combined tumor PTT/SDT in vivo. Besides PA imaging and ICP-MS, in vivo PT imaging was also performed to determine the temperature enhancement at tumor site by intravenously injected TTP under 1064 nm laser excitation for 10 min. The temperature of TTP-treated mice was abruptly increased from 28 to 52 ℃, while a slight temperature change was noticed in PBS group (Fig. <xref rid="Fig5" ref-type="fig">5</xref>D, E). These results demonstrated the good photothermal performance of TTP in vivo.<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p><bold>A</bold> PA images and <bold>B</bold> the corresponding PA signal intensity of tumor at mentioned time points after <italic>i.v.</italic> injection of TTP (2 mg/mL, 200 μL). <bold>C</bold> The estimation of Ti content in vivo by ICP-MS. <bold>D</bold> The real-time temperature increase and <bold>E</bold> the thermal imaging of mice at tumor tissues after treated with/without TTP under 1064 nm laser irradiation (0.8 W/cm<sup>2</sup>, 10 min)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1253_Fig5_HTML.png" id="MO6"/></fig></p></sec><sec id="Sec13"><title>In vivo synergistic PTT/enhanced SDT</title><p id="Par74">Finally, the therapeutic efficacy of synergistic PTT/enhanced SDT triggered by TTP was investigated. 4T1 tumor-bearing mice with a mean tumor volume of about 80 mm<sup>3</sup> were randomly assigned to seven groups, and received an <italic>i.v.</italic> injection of either TTP (20 mg/kg) or PBS, respectively. The tumor volume of each mice undergo different treatment conditions, was recorded every two days, while after 14 days, all the tumors were dissected, weighed, and photographed. As Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: d the tumor growth, whereas the combined PTT/SDT triggered complete tumor eradication. The in vivo therapeutic effects were further evaluated by TUNEL assay, which showed the highest green fluorescence intensity in the combined TPP + Laser + US treatment group (Fig. <xref rid="Fig6" ref-type="fig">6</xref>D), indicating substantial cellular apoptosis. Similarly, the H&amp;E staining of tumor tissues verified the superior therapeutic effects as noticeable nuclear shrinkage and reduced number of cancer cells (Fig. <xref rid="Fig6" ref-type="fig">6</xref>E) were found in combined treatment than individual PTT or SDT alone. These results are in accordance with the in vitro findings. Remarkably, the body weight of the mice in each group was remained stable after different treatments (Fig. <xref rid="Fig6" ref-type="fig">6</xref>F). In addition, no significant lesions or damages were found in the major organs as confirmed by H&amp;E staining (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S23) and blood biochemistry analysis (Fig. <xref rid="Fig6" ref-type="fig">6</xref>G, H), implying the negligible systemic toxicity of TTP in vivo.<fig id="Fig6"><label>Fig. 6</label><caption xml:lang="en"><p><bold>A</bold> Relative change in tumor volume after different treatments. <bold>B</bold> The digital images and <bold>C</bold> the weight of tumors collected from different indicated groups at 14th day. <bold>D</bold> TUNEL assay and <bold>E</bold> H&amp;E-stained images of tumor tissues after different treatments at day 14th. The scale bars are 50 and 100 μm in <bold>D</bold> and <bold>E</bold>, respectively. <bold>F</bold> Relative change in the body weight of mice during different treatments. Levels of different blood biochemical indicators <bold>G</bold> BUN and CRE, <bold>H</bold> ALT and AST in mice serum after different treatments for 14 days. Statistical significance compared with the PBS group is shown (*<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001 and ****<italic>p</italic> &lt; 0.0001)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1253_Fig6_HTML.png" id="MO7"/></fig></p></sec></sec><sec id="Sec14" sec-type="conclusions"><title>Conclusion</title><p id="Par75">In summary, TTP was prepared by the <italic>in-situ</italic> fabrication of ~ 10 nm TiO<sub>2-x</sub> NPs with multiple oxygen defects onto the Ti<sub>3</sub>C<sub>2</sub> nanosheets, followed by PEG grafting, offering synergistic PTT/enhanced SDT under PA/PT bimodal imaging guidance in second biowindow. TTP possessed good colloidal stability, excellent photothermal conversion efficiency, and absorption in NIR-II region. Importantly, TTP with higher surface area and several oxygen-defects, facilitated higher surface adsorption of O<sub>2</sub> molecules as well as an efficient separation of charge carriers under US activation, promoting an enhanced interaction of charge carriers with surface adsorbed O<sub>2</sub> to trigger higher sonodynamic ROS generation than commonly reported TiO<sub>2</sub> NPs. Owing to good photothermal and enhanced US-stimulated ROS production capacity, TTP showed high therapeutic efficiency in vitro with appreciable biocompatibility, and demonstrated complete tumor elimination in 4T1 tumor bearing mice in vivo<italic>,</italic> because of synergistic photothermal enhanced SDT, which is far greater than single treatment modality. Our work demonstrated the design engineering of hybrid nanosystems for enhanced theranostics of deeply localized tumors in clinic.</p></sec></body><back><ack><title>Acknowledgements</title><p>This work is financially supported by National Key R&amp;D Program of China (2018YFA0704000), National Natural Science Foundation of China (82071985), Basic Research Program of Shenzhen (JCYJ20180507182413022, JCYJ20170412111100742), Guangdong Province Natural Science Foundation of Major Basic Research and Cultivation Project (2018B030308003), Shenzhen Science and Technology Program (KQTD20190929172538530) and the Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China (161032). We thank Instrumental Analysis Center of Shenzhen University (Lihu Campus).</p></ack><sec sec-type="author-contribution"><title>Authors' contributions</title><p>YZ, HL, and MRY: Investigation, Data curation, Writing—original draft.  SL and YC: Writing—review &amp; editing. JL &amp; PH, Conceptualization, Supervision, Funding acquisition, Writing—review &amp; editing. All authors read and approved the final manuscript.</p></sec><sec><title>Funding</title><p>This work is financially supported by Basic Research Program of Shenzhen (JCYJ20200109105620482, JCYJ20180507182413022), and Shenzhen Science and Technology Program (KQTD20190929172538530). We thank Instrumental Analysis Center of Shenzhen University (Lihu Campus).</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>All data used to generate these results is available in the main text and supporting information.</p></sec><sec sec-type="ethics-statement"><title>Declarations</title><sec id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par76">All animal studies were approved by the Animal Ethics and Welfare Committee of Shenzhen University.</p></sec><sec id="FPar2"><title>Consent for publication</title><p id="Par77">All authors agree to be published.</p></sec><sec id="FPar3" sec-type="COI-statement"><title>Competing interests</title><p id="Par78">The authors declare no conflict of interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>KD</given-names></name><name><surname>Nogueira</surname><given-names>L</given-names></name><name><surname>Mariotto</surname><given-names>AB</given-names></name><name><surname>Rowland</surname><given-names>JH</given-names></name><name><surname>Yabroff</surname><given-names>KR</given-names></name><name><surname>Alfano</surname><given-names>CM</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name><name><surname>Kramer</surname><given-names>JL</given-names></name><name><surname>Siegel</surname><given-names>RL</given-names></name></person-group><article-title xml:lang="en">Cancer treatment and survivorship statistics, 2019</article-title><source>CA-Cancer J Clin</source><year>2019</year><volume>69</volume><fpage>363</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">31184787</pub-id><pub-id pub-id-type="doi">10.3322/caac.21565</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>C</given-names></name><name><surname>Her</surname><given-names>S</given-names></name><name><surname>Jaffray</surname><given-names>DA</given-names></name></person-group><article-title xml:lang="en">Radiotherapy for cancer: Present and future</article-title><source>Adv Drug Deliv Rev</source><year>2017</year><volume>109</volume><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXisV2qsrY%3D</pub-id><pub-id pub-id-type="pmid">28189183</pub-id><pub-id pub-id-type="doi">10.1016/j.addr.2017.01.004</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasan</surname><given-names>N</given-names></name><name><surname>Baselga</surname><given-names>J</given-names></name><name><surname>Hyman</surname><given-names>DM</given-names></name></person-group><article-title xml:lang="en">A view on drug resistance in cancer</article-title><source>Nature</source><year>2019</year><volume>575</volume><fpage>299</fpage><lpage>309</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXitFKhsrzK</pub-id><pub-id pub-id-type="pmid">31723286</pub-id><pub-id pub-id-type="pmcid">8008476</pub-id><pub-id pub-id-type="doi">10.1038/s41586-019-1730-1</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donaldson</surname><given-names>SS</given-names></name><name><surname>Lenon</surname><given-names>RA</given-names></name><name><surname>Donaldson</surname><given-names>SS</given-names></name></person-group><article-title xml:lang="en">Alterations of nutritional status. Impact of chemotherapy and radiation therapy</article-title><source>Cancer.</source><year>2015</year><volume>43</volume><fpage>2036</fpage><lpage>2052</lpage><pub-id pub-id-type="doi">10.1002/1097-0142(197905)43:5+&lt;2036::AID-CNCR2820430712&gt;3.0.CO;2-7</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soussain</surname><given-names>C</given-names></name><name><surname>Ricard</surname><given-names>DD</given-names></name><name><surname>Fike</surname><given-names>JR</given-names></name><name><surname>Mazeron</surname><given-names>JJ</given-names></name><name><surname>Delattre</surname><given-names>JY</given-names></name></person-group><article-title xml:lang="en">CNS complications of radiotherapy and chemotherapy</article-title><source>Lancet</source><year>2009</year><volume>374</volume><fpage>1639</fpage><lpage>1651</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXhtlyjtLrF</pub-id><pub-id pub-id-type="pmid">19897130</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(09)61299-X</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tohme</surname><given-names>S</given-names></name><name><surname>Simmons</surname><given-names>RL</given-names></name><name><surname>Tsung</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Surgery for cancer: A trigger for metastases</article-title><source>Cancer Res</source><year>2017</year><volume>77</volume><fpage>1548</fpage><lpage>1552</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXltlyjt7s%3D</pub-id><pub-id pub-id-type="pmid">28330928</pub-id><pub-id pub-id-type="pmcid">5380551</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-16-1536</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>F</given-names></name><name><surname>Chao</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Newly developed strategies for improving sonodynamic therapy</article-title><source>Mater Horiz</source><year>2020</year><volume>7</volume><fpage>2028</fpage><lpage>2046</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhtFGltL%2FN</pub-id><pub-id pub-id-type="doi">10.1039/D0MH00613K</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>F</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Ni</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group><article-title xml:lang="en">Preparation of TiH1.924 nanodots by liquid-phase exfoliation for enhanced sonodynamic cancer therapy</article-title><source>Nat Commun.</source><year>2020</year><volume>11</volume><fpage>3712</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhsVOru7%2FL</pub-id><pub-id pub-id-type="pmid">32709842</pub-id><pub-id pub-id-type="pmcid">7381661</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-17485-x</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Micro/nanoparticle-augmented sonodynamic therapy (SDT): Breaking the depth shallow of photoactivation</article-title><source>Adv Mater</source><year>2016</year><volume>28</volume><fpage>8097</fpage><lpage>8129</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhtFersLnN</pub-id><pub-id pub-id-type="pmid">27384408</pub-id><pub-id pub-id-type="doi">10.1002/adma.201602012</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fei</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Liang, Cheng, Nailin, Yang, Oshra, Betzer, Liangzhu, Feng: Ultrasmall oxygen-deficient bimetallic oxide MnWO<sub>x</sub> nanoparticles for depletion of endogenous gsh and enhanced sonodynamic cancer therapy</article-title><source>Adv Mater</source><year>2019</year><volume>31</volume><fpage>1900730</fpage><pub-id pub-id-type="doi">10.1002/adma.201900730</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Metalloporphyrin-encapsulated biodegradable nanosystems for highly efficient magnetic resonance imaging-guided sonodynamic cancer therapy</article-title><source>J Am Chem Soc</source><year>2017</year><volume>139</volume><fpage>1275</fpage><lpage>1284</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XitFCqtLrO</pub-id><pub-id pub-id-type="pmid">28024395</pub-id><pub-id pub-id-type="doi">10.1021/jacs.6b11846</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>Q</given-names></name><name><surname>Leung</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">Natural products in the discovery of novel sonosensitizers</article-title><source>Pharmacol Ther</source><year>2016</year><volume>162</volume><fpage>144</fpage><lpage>151</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXitVGrt7rN</pub-id><pub-id pub-id-type="pmid">26706240</pub-id><pub-id pub-id-type="doi">10.1016/j.pharmthera.2015.12.004</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Pang</surname><given-names>X</given-names></name><name><surname>Lv</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">A single-step multi-level supramolecular system for cancer sonotheranostics</article-title><source>Nanoscale Horiz</source><year>2019</year><volume>4</volume><fpage>190</fpage><lpage>195</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXhvVamt7%2FO</pub-id><pub-id pub-id-type="pmid">32254155</pub-id><pub-id pub-id-type="doi">10.1039/C8NH00276B</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murdoch</surname><given-names>M</given-names></name><name><surname>Waterhouse</surname><given-names>GIN</given-names></name><name><surname>Nadeem</surname><given-names>MA</given-names></name><name><surname>Metson</surname><given-names>JB</given-names></name><name><surname>Keane</surname><given-names>MA</given-names></name><name><surname>Howe</surname><given-names>RF</given-names></name><name><surname>Llorca</surname><given-names>J</given-names></name><name><surname>Idriss</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">The effect of gold loading and particle size on photocatalytic hydrogen production from ethanol over Au/TiO<sub>2</sub> nanoparticles</article-title><source>Nat Chem</source><year>2011</year><volume>3</volume><fpage>489</fpage><lpage>492</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXmtV2htbw%3D</pub-id><pub-id pub-id-type="pmid">21602866</pub-id><pub-id pub-id-type="doi">10.1038/nchem.1048</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Jing</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Oxygen-deficient black titania for synergistic/enhanced sonodynamic and photoinduced cancer therapy at near infrared-II biowindow</article-title><source>ACS Nano</source><year>2018</year><volume>12</volume><fpage>4545</fpage><lpage>4555</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXosVertrc%3D</pub-id><pub-id pub-id-type="pmid">29697960</pub-id><pub-id pub-id-type="doi">10.1021/acsnano.8b00899</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Ultrafine titanium monoxide (TiO<sub>1+x</sub>) nanorods for enhanced sonodynamic therapy</article-title><source>J Am Chem Soc</source><year>2020</year><volume>142</volume><fpage>6527</fpage><lpage>6537</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXlt1CqsLo%3D</pub-id><pub-id pub-id-type="pmid">32191455</pub-id><pub-id pub-id-type="doi">10.1021/jacs.9b10228</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deepagan</surname><given-names>VG</given-names></name><name><surname>You</surname><given-names>DG</given-names></name><name><surname>Um</surname><given-names>W</given-names></name><name><surname>Ko</surname><given-names>H</given-names></name><name><surname>Kwon</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>KY</given-names></name><name><surname>Yi</surname><given-names>G-R</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>DS</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Long-circulating Au-TiO<sub>2</sub> nanocomposite as a sonosensitizer for ROS-mediated eradication of cancer</article-title><source>Nano Lett</source><year>2016</year><volume>16</volume><fpage>6257</fpage><lpage>6264</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhsFanu7bP</pub-id><pub-id pub-id-type="pmid">27643533</pub-id><pub-id pub-id-type="doi">10.1021/acs.nanolett.6b02547</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">TiO<sub>2</sub> nanosheets with au nanocrystals decorated edge for mitochondria-targeting enhanced sonodynamic therapy</article-title><source>Chem Mater</source><year>2019</year><volume>31</volume><fpage>9105</fpage><lpage>9114</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXhvFyiur3F</pub-id><pub-id pub-id-type="doi">10.1021/acs.chemmater.9b03430</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>DY</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>JH</given-names></name><name><surname>Tan</surname><given-names>CP</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Ji</surname><given-names>LN</given-names></name><name><surname>Mao</surname><given-names>ZW</given-names></name></person-group><article-title xml:lang="en">Delivery of phosphorescent anticancer iridium (III) complexes by polydopamine nanoparticles for targeted combined photothermal-chemotherapy and thermal/photoacoustic/lifetime imaging</article-title><source>Adv Sci</source><year>2018</year><volume>5</volume><fpage>1800581</fpage><pub-id pub-id-type="doi">10.1002/advs.201800581</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Bai</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Jacobson</surname><given-names>O</given-names></name><name><surname>Fan</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Core-satellite polydopamine-gadolinium-metallofullerene nanotheranostics for multimodal imaging guided combination cancer therapy</article-title><source>Adv Mater</source><year>2017</year><volume>29</volume><fpage>1701013</fpage><pub-id pub-id-type="doi">10.1002/adma.201701013</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>DY</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>T</given-names></name><name><surname>Younis</surname><given-names>MR</given-names></name><name><surname>Zeng</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">Cobalt carbide-based theranostic agents for in vivo multimodal imaging guided photothermal therapy</article-title><source>Nanoscale</source><year>2020</year><volume>12</volume><fpage>7174</fpage><lpage>7179</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXltlCkurw%3D</pub-id><pub-id pub-id-type="pmid">32195531</pub-id><pub-id pub-id-type="doi">10.1039/D0NR00468E</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>ZH</given-names></name><name><surname>Pan</surname><given-names>P</given-names></name><name><surname>Hu</surname><given-names>JJ</given-names></name><name><surname>Cheng</surname><given-names>SX</given-names></name><name><surname>Zhang</surname><given-names>XZ</given-names></name></person-group><article-title xml:lang="en">Tumor-microenvironment-triggered ion exchange of a metal-organic framework hybrid for multimodal imaging and synergistic therapy of tumors</article-title><source>Adv Mater</source><year>2020</year><volume>32</volume><fpage>2001452</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXoslehu7s%3D</pub-id><pub-id pub-id-type="doi">10.1002/adma.202001452</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer</article-title><source>Biomaterials.</source><year>2019</year><volume>217</volume><fpage>119264</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXht1Oqu7rJ</pub-id><pub-id pub-id-type="pmid">31260883</pub-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2019.119264</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Younis</surname><given-names>MR</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>An</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Younis</surname><given-names>MA</given-names></name><name><surname>Li</surname><given-names>Z-Q</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ihsan</surname><given-names>A</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name><name><surname>Xia</surname><given-names>X-H</given-names></name></person-group><article-title xml:lang="en">Low power single laser activated synergistic cancer phototherapy using photosensitizer functionalized dual plasmonic photothermal nanoagents</article-title><source>ACS Nano</source><year>2019</year><volume>13</volume><fpage>2544</fpage><lpage>2557</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXisFyisrw%3D</pub-id><pub-id pub-id-type="pmid">30730695</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>L-H</given-names></name><name><surname>Qi</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>Y-R</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Glucose oxidase-instructed multimodal synergistic cancer therapy</article-title><source>Adv Mater</source><year>2019</year><volume>31</volume><fpage>1808325</fpage><pub-id pub-id-type="doi">10.1002/adma.201808325</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>T</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Blum</surname><given-names>NT</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Light-triggered transformable ferrous ion delivery system for photothermal primed chemodynamic therapy</article-title><source>Angew Chem Int Ed</source><year>2021</year><volume>60</volume><fpage>6047</fpage><lpage>6054</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXjtFKrurk%3D</pub-id><pub-id pub-id-type="doi">10.1002/anie.202015379</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Younis</surname><given-names>MR</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Qu</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Programmable NIR-II photothermal-enhanced starvation-primed chemodynamic therapy using glucose oxidase-functionalized ancient pigment nanosheets</article-title><source>Small</source><year>2020</year><volume>16</volume><fpage>2001518</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhtVGgs7fO</pub-id><pub-id pub-id-type="doi">10.1002/smll.202001518</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>T</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Blum</surname><given-names>NT</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Plasmonic modulation of gold nanotheranostics for targeted NIR-II photothermal-augmented immunotherapy</article-title><source>Nano Today.</source><year>2020</year><volume>35</volume><fpage>100987</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXos1Kqs7Y%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.nantod.2020.100987</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group><article-title xml:lang="en">Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide</article-title><source>ACS Nano</source><year>2011</year><volume>5</volume><fpage>7000</fpage><lpage>7009</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXpvFChsbs%3D</pub-id><pub-id pub-id-type="pmid">21815655</pub-id><pub-id pub-id-type="doi">10.1021/nn201560b</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>DY</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>CP</given-names></name><name><surname>Sun</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Ji</surname><given-names>LN</given-names></name><name><surname>Mao</surname><given-names>ZW</given-names></name></person-group><article-title xml:lang="en">Graphene oxide decorated with Ru(II)-polyethylene glycol complex for lysosome-targeted imaging and photodynamic/photothermal therapy</article-title><source>ACS Appl Mater Interfaces</source><year>2017</year><volume>9</volume><fpage>6761</fpage><lpage>6771</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXitVert7c%3D</pub-id><pub-id pub-id-type="pmid">28150943</pub-id><pub-id pub-id-type="doi">10.1021/acsami.6b13808</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Intelligent hollow Pt-CuS janus architecture for synergistic catalysis-enhanced sonodynamic and photothermal cancer therapy</article-title><source>Nano Lett</source><year>2019</year><volume>19</volume><fpage>4134</fpage><lpage>4145</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXpsVOltr4%3D</pub-id><pub-id pub-id-type="pmid">31084016</pub-id><pub-id pub-id-type="doi">10.1021/acs.nanolett.9b01595</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C-Q</given-names></name><name><surname>Zhao</surname><given-names>D-H</given-names></name><name><surname>Hou</surname><given-names>X-L</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Song</surname><given-names>L-B</given-names></name><name><surname>Jin</surname><given-names>R-M</given-names></name><name><surname>Zhao</surname><given-names>Y-D</given-names></name><name><surname>Liu</surname><given-names>BL</given-names></name></person-group><article-title xml:lang="en">In situ synthesis of multifunctional tellurium nanorods stabilized by polypeptide-engineered for photothermal-sonodynamic combination therapy of tumors</article-title><source>Chem Eng J.</source><year>2021</year><volume>417</volume><fpage>127989</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXisFelsLnL</pub-id><pub-id pub-id-type="doi">10.1016/j.cej.2020.127989</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Theranostic 2D tantalum carbide (Mxene)</article-title><source>Adv Mater</source><year>2018</year><volume>30</volume><fpage>1703284</fpage><pub-id pub-id-type="doi">10.1002/adma.201703284</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>W</given-names></name><name><surname>Ai</surname><given-names>K</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Plasmonic titanium nitride nanoparticles for in vivo photoacoustic tomography imaging and photothermal cancer therapy</article-title><source>Biomaterials</source><year>2017</year><volume>132</volume><fpage>37</fpage><lpage>47</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXlvVGgt7Y%3D</pub-id><pub-id pub-id-type="pmid">28407493</pub-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.04.007</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Alshareef</surname><given-names>NH</given-names></name><name><surname>Quevedo-Lopez</surname><given-names>MA</given-names></name><name><surname>Salama</surname><given-names>KN</given-names></name></person-group><article-title xml:lang="en">Biofunctionalized two-dimensional Ti<sub>3</sub>C<sub>2</sub>&amp;nbsp;MXenes for ultrasensitive detection of cancer biomarker</article-title><source>Biosens Bioelectron</source><year>2018</year><volume>121</volume><fpage>243</fpage><lpage>249</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXhslahtrzN</pub-id><pub-id pub-id-type="pmid">30219724</pub-id><pub-id pub-id-type="doi">10.1016/j.bios.2018.08.076</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Biocompatible 2D titanium carbide (Mxenes) composite nanosheets for pH-responsive MRI-guided tumor hyperthermia</article-title><source>Chem Mater</source><year>2017</year><volume>29</volume><fpage>8637</fpage><lpage>8652</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhsVWnurbP</pub-id><pub-id pub-id-type="doi">10.1021/acs.chemmater.7b02441</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Cui</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>S-W</given-names></name><name><surname>Yu</surname><given-names>X-F</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Fluorine-free preparation of titanium carbide mxene quantum dots with high near-infrared photothermal performances for cancer therapy</article-title><source>Nanoscale</source><year>2017</year><volume>9</volume><fpage>17859</fpage><lpage>17864</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhs12lur%2FN</pub-id><pub-id pub-id-type="pmid">29119157</pub-id><pub-id pub-id-type="doi">10.1039/C7NR05997C</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Biodegradable and excretable 2D W133C i-MXene with vacancy ordering for theory-oriented cancer nanotheranostics in near-infrared biowindow</article-title><source>Adv Sci.</source><year>2021</year><volume>1</volume><fpage>2101043</fpage><pub-id pub-id-type="doi">10.1002/advs.202101043</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Two-dimensional biomaterials: material science, biological effect and biomedical engineering applications</article-title><source>Chem Soc Rev</source><year>2021</year><volume>50</volume><fpage>11381</fpage><lpage>11485</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXhvVagsLbK</pub-id><pub-id pub-id-type="pmid">34661206</pub-id><pub-id pub-id-type="doi">10.1039/D0CS01138J</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Ultrathin molybdenum carbide MXene with fast biodegradability for highly efficient theory-oriented photonic tumor hyperthermia</article-title><source>Adv Funct Mater</source><year>2019</year><volume>29</volume><fpage>1901942</fpage><pub-id pub-id-type="doi">10.1002/adfm.201901942</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Mao C, Zuo F, Hou Y, Bu X, Feng P. In situ preparation of a Ti<sup>3+</sup> self-doped TiO<sub>2</sub> film with enhanced activity as photoanode by N<sub>2</sub>H<sub>4</sub> reduction. Angew Chem Int Ed .2014, 53: 10485–9.</mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><article-title xml:lang="en">Reactive oxygen species-manipulated drug release from a smart envelope-type mesoporous titanium nanovehicle for tumor sonodynamic-chemotherapy</article-title><source>ACS Appl Mater Interfaces</source><year>2015</year><volume>7</volume><fpage>28554</fpage><lpage>28565</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhvVOrt7zL</pub-id><pub-id pub-id-type="pmid">26587885</pub-id><pub-id pub-id-type="doi">10.1021/acsami.5b09937</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Hou</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Ding</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Han</surname><given-names>G</given-names></name><name><surname>Kheraif</surname><given-names>AAA</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">A multifunctional nanovaccine based on L-arginine-loaded black mesoporous titania: Ultrasound-triggered synergistic cancer sonodynamic therapy/gas therapy/immunotherapy with remarkably enhanced efficacy</article-title><source>Small</source><year>2021</year><volume>17</volume><fpage>2005728</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXhvVSgtLw%3D</pub-id><pub-id pub-id-type="doi">10.1002/smll.202005728</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>K</given-names></name><name><surname>Tan</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Cui</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Rapid photo-sonotherapy for clinical treatment of bacterial infected bone implants by creating oxygen deficiency using sulfur doping</article-title><source>ACS Nano</source><year>2020</year><volume>14</volume><fpage>2077</fpage><lpage>2089</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhs12msrs%3D</pub-id><pub-id pub-id-type="pmid">31990179</pub-id><pub-id pub-id-type="doi">10.1021/acsnano.9b08686</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Kong</surname><given-names>D</given-names></name><name><surname>Hsu</surname><given-names>P-C</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>H-W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Rapid water disinfection using vertically aligned MoS<sub>2</sub> nanofilms and visible light</article-title><source>Nat Nanotechnol</source><year>2016</year><volume>11</volume><fpage>1098</fpage><lpage>1104</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhtlCitb7E</pub-id><pub-id pub-id-type="pmid">27525474</pub-id><pub-id pub-id-type="doi">10.1038/nnano.2016.138</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Yuan</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">In-situ construction of hierarchical accordion-like TiO<sub>2</sub>/Ti<sub>3</sub>C<sub>2</sub> nanohybrid as anode material for lithium and sodium ion batteries</article-title><source>Electrochim Acta</source><year>2018</year><volume>271</volume><fpage>165</fpage><lpage>172</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXmsVentb8%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.electacta.2018.03.118</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>Y</given-names></name><name><surname>Hardwick</surname><given-names>LJ</given-names></name><name><surname>Bruce</surname><given-names>PG</given-names></name></person-group><article-title xml:lang="en">Lithium intercalation into mesoporous anatase with an ordered 3D pore structure</article-title><source>Angew Chem Int Ed</source><year>2010</year><volume>122</volume><fpage>2624</fpage><lpage>2628</lpage><pub-id pub-id-type="doi">10.1002/ange.200907099</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Wan</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Visible-light photocatalytic, solar thermal and photoelectrochemical properties of aluminium-reduced black titania</article-title><source>Energy Environ Sci</source><year>2013</year><volume>6</volume><fpage>3007</fpage><lpage>3014</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXhsV2it7nI</pub-id><pub-id pub-id-type="doi">10.1039/c3ee41817k</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Lü</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Effective nonmetal incorporation in black titania with enhanced solar energy utilization</article-title><source>Energy Environ Sci</source><year>2014</year><volume>7</volume><fpage>967</fpage><lpage>972</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXjtlKisbs%3D</pub-id><pub-id pub-id-type="doi">10.1039/c3ee42708k</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suk</surname><given-names>JS</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Hanes</surname><given-names>J</given-names></name><name><surname>Ensign</surname><given-names>LM</given-names></name></person-group><article-title xml:lang="en">Pegylation as a strategy for improving nanoparticle-based drug and gene delivery</article-title><source>Adv Drug Deliv Rev</source><year>2016</year><volume>99</volume><fpage>28</fpage><lpage>51</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhs1CqurrP</pub-id><pub-id pub-id-type="pmid">26456916</pub-id><pub-id pub-id-type="doi">10.1016/j.addr.2015.09.012</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D-Y</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>G-G</given-names></name><name><surname>Tan</surname><given-names>C-P</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Ji</surname><given-names>L-N</given-names></name><name><surname>Mao</surname><given-names>Z-W</given-names></name></person-group><article-title xml:lang="en">Folate receptor-targeted theranostic IrS<sub>x</sub> nanoparticles for multimodal imaging-guided combined chemo-photothermal therapy</article-title><source>Nanoscale</source><year>2018</year><volume>10</volume><fpage>22252</fpage><lpage>22262</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXitVOiu7jF</pub-id><pub-id pub-id-type="pmid">30465053</pub-id><pub-id pub-id-type="doi">10.1039/C8NR08095J</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Tang Ya, Liu L, Lv X, Wang Q, Ke H, Deng Y, Yang H, Yang X, Liu G: Size-dependent Ag<sub>2</sub>S nanodots for second near-infrared fluorescence/photoacoustics imaging and simultaneous photothermal therapy</article-title><source>ACS Nano</source><year>2017</year><volume>11</volume><fpage>1848</fpage><lpage>1857</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhsFGhtLs%3D</pub-id><pub-id pub-id-type="pmid">28117993</pub-id><pub-id pub-id-type="doi">10.1021/acsnano.6b07866</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hessel</surname><given-names>CM</given-names></name><name><surname>Pattani</surname><given-names>VP</given-names></name><name><surname>Rasch</surname><given-names>M</given-names></name><name><surname>Panthani</surname><given-names>MG</given-names></name><name><surname>Koo</surname><given-names>B</given-names></name><name><surname>Tunnell</surname><given-names>JW</given-names></name><name><surname>Korgel</surname><given-names>BA</given-names></name></person-group><article-title xml:lang="en">Copper selenide nanocrystals for photothermal therapy</article-title><source>Nano Lett</source><year>2011</year><volume>11</volume><fpage>2560</fpage><lpage>2566</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXlvFClsbY%3D</pub-id><pub-id pub-id-type="pmid">21553924</pub-id><pub-id pub-id-type="pmcid">3111000</pub-id><pub-id pub-id-type="doi">10.1021/nl201400z</pub-id></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Q</given-names></name><name><surname>Jiang</surname><given-names>F</given-names></name><name><surname>Zou</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Hydrophilic Cu9S5 nanocrystals: a photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo</article-title><source>ACS Nano.</source><year>2011</year><volume>1</volume><issue>5</issue><fpage>9761</fpage><pub-id pub-id-type="doi">10.1021/nn203293t</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Su</surname><given-names>Q</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Sub-10 nm Fe<sub>3</sub>O<sub>4</sub>@Cu<sub>2–x</sub>S core–shell nanoparticles for dual-modal imaging and photothermal therapy</article-title><source>J Am Chem Soc</source><year>2013</year><volume>135</volume><fpage>8571</fpage><lpage>8577</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXnvFyitLg%3D</pub-id><pub-id pub-id-type="pmid">23687972</pub-id><pub-id pub-id-type="doi">10.1021/ja4013497</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">An ultrasound activated vesicle of janus Au-MnO nanoparticles for promoted tumor penetration and sono-chemodynamic therapy of orthotopic liver cancer</article-title><source>Angew Chem Int Ed</source><year>2020</year><volume>59</volume><fpage>1682</fpage><lpage>1688</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXitleqsbbI</pub-id><pub-id pub-id-type="doi">10.1002/anie.201912768</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>F</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Ultrasmall iron-doped titanium oxide nanodots for enhanced sonodynamic and chemodynamic cancer therapy</article-title><source>ACS Nano</source><year>2020</year><volume>14</volume><fpage>15119</fpage><lpage>15130</lpage><pub-id pub-id-type="pmid">33185089</pub-id><pub-id pub-id-type="doi">10.1021/acsnano.0c05235</pub-id></mixed-citation></ref></ref-list></ref-list><app-group><app id="App1" specific-use="web-only"><sec id="Sec15"><title>Supplementary Information</title><p id="Par79"><supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary Information"><media mimetype="application" mime-subtype="msword" xlink:href="MediaObjects/12951_2022_1253_MOESM1_ESM.docx" position="anchor"><caption xml:lang="en"><p><bold>Additional file 1.</bold> Additional information includes part of material and methods, additional figures and tables.</p></caption></media></supplementary-material></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>NIR-I</term><def><p id="Par4">Near-infrared-I</p></def></def-item><def-item><term>ROS</term><def><p id="Par5">Reactive oxygen species</p></def></def-item><def-item><term>PTT</term><def><p id="Par6">Photothermal therapy</p></def></def-item><def-item><term>US</term><def><p id="Par7">Ultrasound</p></def></def-item><def-item><term>SDT</term><def><p id="Par8">Sonodynamic therapy</p></def></def-item><def-item><term>TiO<sub>2</sub></term><def><p id="Par9">Titanium dioxide</p></def></def-item><def-item><term>Ti<sub>3</sub>C<sub>2</sub></term><def><p id="Par10">Titanium carbide</p></def></def-item><def-item><term>PA</term><def><p id="Par11">Photoacoustic;</p></def></def-item><def-item><term>PEG</term><def><p id="Par12">Polyethylene glycol</p></def></def-item><def-item><term>TPAOH</term><def><p id="Par13">Tetrapropylammonium hydroxide</p></def></def-item><def-item><term>DSPE-PEG</term><def><p id="Par14">1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)</p></def></def-item><def-item><term>TPA</term><def><p id="Par15">Terephthalic acid</p></def></def-item><def-item><term>MTT</term><def><p id="Par16">3-(4,5)-Dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide</p></def></def-item><def-item><term>PI</term><def><p id="Par17">Propidium iodide</p></def></def-item><def-item><term>TEM</term><def><p id="Par18">Transmission electron microscope</p></def></def-item><def-item><term>XPS</term><def><p id="Par19">X-ray photoelectron spectrometer</p></def></def-item><def-item><term>FT-IR</term><def><p id="Par20">Fourier transform infrared</p></def></def-item><def-item><term>TGA</term><def><p id="Par21">Thermo-gravimetric analysis</p></def></def-item><def-item><term>DLS</term><def><p id="Par22">Dynamic light scattering</p></def></def-item><def-item><term>ICP-MS</term><def><p id="Par23">Inductively coupled plasma mass spectrometry</p></def></def-item><def-item><term>TTP</term><def><p id="Par24">Ti<sub>3</sub>C<sub>2</sub>@TiO<sub>2-x</sub>-PEG</p></def></def-item><def-item><term>PBS</term><def><p id="Par25">Phosphate buffered saline</p></def></def-item><def-item><term>H&amp;E</term><def><p id="Par26">Hematoxylin and eosin</p></def></def-item><def-item><term>TUNEL</term><def><p id="Par27">Terminal-deoxynucleoitidyl transferase mediated nick end labeling</p></def></def-item><def-item><term>SAED</term><def><p id="Par28">Selected area electron diffraction</p></def></def-item><def-item><term>EDS</term><def><p id="Par29">Energy dispersive X-ray spectroscopy</p></def></def-item><def-item><term>XRD</term><def><p id="Par30">X-ray diffraction</p></def></def-item><def-item><term>DMEM</term><def><p id="Par31">Dulbecco’s modified eagle medium</p></def></def-item><def-item><term>FBS</term><def><p id="Par32">Fetal bovine serum</p></def></def-item><def-item><term><sup>1</sup>O<sub>2</sub></term><def><p id="Par33">Singlet oxygen</p></def></def-item><def-item><term>·OH</term><def><p id="Par34">Hydroxyl radicals</p></def></def-item><def-item><term>ESR</term><def><p id="Par35">Electron spin resonance</p></def></def-item><def-item><term>DPBF</term><def><p id="Par36">1, 3-Diphenylisobenzofuran</p></def></def-item><def-item><term>DMPO</term><def><p id="Par37">5,5-Dimethyl-1-pyrroline N-oxide</p></def></def-item><def-item><term>HEK 293 T</term><def><p id="Par38">Human embryonic kidney 293 T</p></def></def-item><def-item><term>DCFH-DA</term><def><p id="Par39">2,7-Dichlorofluorescein diacetate</p></def></def-item><def-item><term>AST</term><def><p id="Par40">Aspartate transaminase</p></def></def-item><def-item><term>ALT</term><def><p id="Par41">Alanine aminotransferase</p></def></def-item><def-item><term>BUN</term><def><p id="Par42">Blood urea nitrogen</p></def></def-item><def-item><term>CRE</term><def><p id="Par43">Creatinine</p></def></def-item><def-item><term>HGB</term><def><p id="Par44">Hemoglobin</p></def></def-item><def-item><term>MCHC</term><def><p id="Par45">Mean corpuscular hemoglobin concentration</p></def></def-item><def-item><term>PLT</term><def><p id="Par46">Platelets</p></def></def-item><def-item><term>RBC</term><def><p id="Par47">Red blood cells</p></def></def-item><def-item><term>MPV</term><def><p id="Par48">Mean platelet volume</p></def></def-item><def-item><term>MCH</term><def><p id="Par49">Mean corpuscular hemoglobin</p></def></def-item><def-item><term>WBC</term><def><p id="Par50">White blood cells</p></def></def-item><def-item><term>LYM</term><def><p id="Par51">Lymphocyte</p></def></def-item><def-item><term>MON</term><def><p id="Par52">Monocyte</p></def></def-item><def-item><term>HCT</term><def><p id="Par53">Hematocrit</p></def></def-item><def-item><term>MCV</term><def><p id="Par54">Mean corpuscular volume</p></def></def-item><def-item><term>PDW</term><def><p id="Par55">Platelet distribution width</p></def></def-item><def-item><term>O<sub>2</sub></term><def><p id="Par56">Oxygen</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisher's Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Biotechnology</facet-value><facet-value count="1">Chemistry</facet-value><facet-value count="1">Molecular Medicine</facet-value><facet-value count="1">Nanotechnology</facet-value></facet><facet name="keyword"><facet-value count="1">Oxygen deficient titanium dioxide</facet-value><facet-value count="1">Photoacoustic imaging</facet-value><facet-value count="1">Photothermal therapy</facet-value><facet-value count="1">Sonodynamic therapy</facet-value><facet-value count="1">Titanium carbide</facet-value></facet><facet name="pub"><facet-value count="1">Journal of Nanobiotechnology</facet-value></facet><facet name="year"><facet-value count="1">2022</facet-value></facet><facet name="country"><facet-value count="1">China</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
